Our results suggest that ROS/ERK/TGF-β/periostin pathway may contribute to myocardial fibrosis in DCM and resveratrol has a therapeutic potential in ameliorating these processes. The gene discussed is TGFB1; the disease is familial dilated cardiomyopathy.